{
 "generic_name": "Prazosin Hydrochloride Capsule",
 "slug": "prazosin-hydrochloride-capsule",
 "brand_names": [],
 "fda_status": [
  "To Be Discontinued"
 ],
 "last_fda_update": "04/28/2023",
 "first_posted": "04/28/2023",
 "synced_at": "2026-10-01T04:04:04.751Z",
 "presentations": [
  {
   "company": "Pfizer Inc.",
   "package_ndc": "0069-4310-71",
   "presentation": "Minipress, Capsule, 1 mg (NDC 0069-4310-71)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "Discontinuation of the manufacture of the drug. Supply expected to exhaust in August 2023"
  },
  {
   "company": "Pfizer Inc.",
   "package_ndc": "0069-4370-71",
   "presentation": "Minipress, Capsule, 2 mg (NDC 0069-4370-71)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "Discontinuation of the manufacture of the drug. Supply expected to exhaust in September 2023"
  },
  {
   "company": "Pfizer Inc.",
   "package_ndc": "0069-4380-71",
   "presentation": "Minipress, Capsule, 5 mg (NDC 0069-4380-71)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "Discontinuation of the manufacture of the drug. Supply expected to exhaust in September 2023"
  }
 ],
 "changes": []
}